---
title: "Haisco: Clinical trial for new indication drug HSK39297 approved"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263964057.md"
description: "According to the Zhitong Finance APP, Haisco announced that the company recently received the \"Drug Clinical Trial Approval Notice\" issued by the National Medical Products Administration's Review Center. The drug name is HSK39297 tablets, and its indication is for generalized myasthenia gravis"
datetime: "2025-11-03T08:20:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263964057.md)
  - [en](https://longbridge.com/en/news/263964057.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263964057.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/263964057.md) | [繁體中文](https://longbridge.com/zh-HK/news/263964057.md)


# Haisco: Clinical trial for new indication drug HSK39297 approved

According to the Zhitong Finance APP, Haisco (002653.SZ) announced that the company recently received the "Drug Clinical Trial Approval Notification" issued by the National Medical Products Administration's Review Center. The drug name is HSK39297 tablets, and its indication is for generalized myasthenia gravis

### Related Stocks

- [Haisco (002653.CN)](https://longbridge.com/en/quote/002653.CN.md)

## Related News & Research

- [Haisco Pharmaceutical Group Gets IND Acceptance for New Prostate Cancer Drug Combinations](https://longbridge.com/en/news/270570277.md)
- [Haisco Pharma Gets Nod for Myasthenia Gravis Drug Trial](https://longbridge.com/en/news/264134306.md)
- [InSilico Out-licensed Drug ISM4808 Begins Clinical Trial](https://longbridge.com/en/news/278010381.md)
- [GLP-1 Feud Ends: NOVO, HIMS Join Forces (Again) To Sell Obesity Drugs](https://longbridge.com/en/news/278234512.md)
- [Abbisko Doses First Patient in Tumor Drug Trial](https://longbridge.com/en/news/277705739.md)